ERYC 125 Uses, Dosage, Side Effects & Benefits
Table of Contents
- Introduction
- Definition of ERYC 125
- Uses and Applications
- Chemical Properties
- Pharmacology
- Forms and Dosage
- Manufacturers and Brand Names
- Side Effects and Precautions
- Pricing and Availability
- Drug Interactions and Contraindications
- Clinical and Experimental Data
- Regulatory Information
- Related Compounds
- Patient Information
- Buyer’s Guide
- Miscellaneous
Introduction
ERYC 125 is an antibiotic medication used to treat various bacterial infections. As a form of erythromycin, ERYC 125 belongs to the macrolide class of antibiotics and works by inhibiting bacterial protein synthesis. This comprehensive guide will provide an in-depth look at ERYC 125, including its uses, dosage, side effects, and benefits.
Definition of ERYC 125
ERYC 125 is a specific formulation of erythromycin, an antibiotic derived from the actinomycete Saccharopolyspora erythraea (formerly classified under Streptomyces erythreus). The chemical composition of erythromycin is C37H67NO13, and it is the main active component in ERYC 125. Erythromycin” target=”_blank”> Erythromycin is a broad-spectrum antibiotic effective against various gram-positive and some gram-negative bacteria.
Uses and Applications
ERYC 125 is primarily used to treat infections caused by gram-positive bacteria, such as Streptococcus, Staphylococcus, and Pneumococcus species. It can be administered orally, parenterally, or topically, depending on the site and severity of the infection. Common conditions treated with ERYC 125 include respiratory tract infections, skin infections, and certain sexually transmitted diseases like chlamydia and syphilis.
Chemical Properties
Erythromycin, the main component of ERYC 125, has a melting point of 135-140°C and a boiling point of 942.8°C at 760 mmHg. Its CAS registry number is 114-07-8. These chemical properties contribute to the stability and effectiveness of ERYC 125 as an antibiotic medication.
Pharmacology
ERYC 125 acts as a protein synthesis inhibitor by binding to the 50S subunit of the bacterial ribosome, preventing the translocation of peptidyl tRNA and inhibiting polypeptide synthesis. This mechanism of action effectively inhibits bacterial growth and replication. Additionally, erythromycin has been shown to affect mammalian mRNA splicing, although the clinical significance of this effect is not well understood.
Forms and Dosage
ERYC 125 is available in various forms and strengths, including ERYC 125 capsules, ERYC sprinkles, ERYC-125, and ERYC-250. The most common dosage is the 125 mg capsule, which is usually taken orally two to four times daily, depending on the severity of the infection and the patient’s age and weight. It is essential to follow the prescribed dosage and complete the entire course of treatment, even if symptoms improve, to prevent the development of antibiotic-resistant bacteria.
Manufacturers and Brand Names
ERYC 125 is manufactured by Parke-Davis, a subsidiary of Pfizer Inc. It is also available under various brand names, such as Erycen, Erycette, Erycin, Erycinum, Erydermer, Erygel, Eryhexal, Erymax, Erymed, and Erysafe. These alternative brand names may vary in their formulations, strengths, and availability depending on the country and manufacturer.
Side Effects and Precautions
As with any medication, ERYC 125 may cause side effects. Common side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Less common side effects may include allergic reactions, liver dysfunction, and QT prolongation. Patients with a history of liver disease, myasthenia gravis, or prolonged QT interval should use ERYC 125 with caution. It is essential to seek medical advice if side effects persist or worsen.
Pricing and Availability
The price of ERYC 125 varies depending on the country, manufacturer, and dosage form. In the United States, the average cost of a 125 mg capsule is approximately $0.85, with prices ranging from $0.50 to $1.50 per capsule. Many online pharmacies offer ERYC 125 with free shipping worldwide, making it accessible to patients in various countries, including Canada, Australia, Mauritius, New Zealand, and the United Kingdom.
Drug Interactions and Contraindications
ERYC 125 may interact with other medications, leading to adverse effects or reduced efficacy. Notable drug interactions include increased risk of QT prolongation when combined with antiarrhythmic agents, ergot alkaloids, and certain antipsychotics. ERYC 125 may also interact with theophylline, carbamazepine, and digoxin, among others. Patients should inform their healthcare provider about all medications they are taking before starting ERYC 125 treatment.
Clinical and Experimental Data
Numerous clinical studies have demonstrated the efficacy and safety of erythromycin, the main component of ERYC 125, in treating various bacterial infections. A randomized, double-blind study published in the Lancet found that erythromycin was effective in treating community-acquired pneumonia, with a clinical success rate of 91%. Another study published in the Journal of Antimicrobial Chemotherapy demonstrated the efficacy of erythromycin in treating skin and soft tissue infections caused by Staphylococcus aureus and Streptococcus pyogenes.
Regulatory Information
ERYC 125 is classified under the AAPCC Code 077712 for systemic antibiotics. The manufacture, distribution, and sale of ERYC 125 are regulated by the Food and Drug Administration (FDA) in the United States and similar regulatory bodies in other countries. Prescription requirements and regulations may vary depending on the country and jurisdiction.
Related Compounds
Erythromycin, the main component of ERYC 125, belongs to the macrolide class of antibiotics. Other macrolide antibiotics include clarithromycin, azithromycin, and roxithromycin. While these antibiotics share similar mechanisms of action, they may differ in their spectrum of activity, pharmacokinetic properties, and potential side effects. In some cases, these related compounds may be used as alternatives to ERYC 125, depending on the specific infection and patient factors.
Patient Information
Patients prescribed ERYC 125 should follow their healthcare provider’s instructions regarding dosage, duration of treatment, and any special considerations. It is important to take ERYC 125 with a full glass of water and to avoid consuming grapefruit juice, as it may increase the risk of side effects. Patients should store ERYC 125 at room temperature, away from light and moisture, and keep it out of reach of children. If a dose is missed, patients should take it as soon as possible, unless it is almost time for the next dose, in which case they should skip the missed dose and continue with the regular schedule.
Buyer’s Guide
When purchasing ERYC 125 online, it is crucial to ensure that the supplier is reputable and the medication is authentic. Patients should look for licensed online pharmacies that require a valid prescription and provide clear information about the product, including its manufacturer, strength, and expiration date. It is also essential to be cautious of significantly low prices or offers that seem too good to be true, as they may indicate counterfeit or substandard products.
Miscellaneous
While taking ERYC 125, patients may consider vitamin and mineral supplementation to support their overall health. However, it is important to note that supplements should not replace a balanced diet and should be used under the guidance of a healthcare professional. If symptoms persist or worsen despite ERYC 125 treatment, patients should consult their healthcare provider promptly.
In conclusion, ERYC 125 is a valuable antibiotic medication for treating various bacterial infections. By understanding its uses, dosage, side effects, and benefits, patients can make informed decisions about their treatment and work with their healthcare providers to achieve optimal outcomes.
